| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2174/156802606777864917 |
| P698 | PubMed publication ID | 16848744 |
| P2093 | author name string | Kazumi Morikawa | |
| Tadakatsu Takahashi | |||
| P2860 | cites work | The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome | Q28183858 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin D | Q175621 |
| drug discovery | Q1418791 | ||
| P304 | page(s) | 1303-1316 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Current Topics in Medicinal Chemistry | Q2734725 |
| P1476 | title | Vitamin D receptor agonists: opportunities and challenges in drug discovery | |
| P478 | volume | 6 |
| Q39383582 | 20-hydroxyvitamin D₃ inhibits proliferation of cancer cells with high efficacy while being non-toxic. |
| Q54845414 | Beyond mineral metabolism, the bright immunomodulatory effect of vitamin D in renal disease. |
| Q39694085 | Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity. |
| Q42535614 | Design, synthesis, and biological action of 20R-hydroxyvitamin D3. |
| Q50047832 | Effects of recombinant human parathyroid hormone (1-34)on cell proliferation, chemokine expression and the Hedgehog pathway in keratinocytes. |
| Q36776598 | Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1. |
| Q34127897 | Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity |
| Q38108294 | Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation |
| Q26849424 | Vitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathy |
Search more.